Recognizing and Responding to Challenges Related to Dinutuximab Administration in the Pediatric Patient with Neuroblastoma-Recognizing and Responding to Challenges Related to Dinutuximab Administration in the Pediatric Patient with Neuroblastoma

Recognizing and Responding to Challenges Related to Dinutuximab Administration in the Pediatric Patient with Neuroblastoma

Back to course

Video Transcription

Video Summary

The presentation focused on dinutuximab use in pediatric neuroblastoma and three major challenges: neurotoxicity, severe infusion reactions, and logistical burden. Speakers reviewed neuroblastoma basics, standard treatment, and why dinutuximab is important: it targets GD2, which is expressed on most neuroblastoma cells, and improves survival in high-risk disease.<br /><br />A single-site retrospective study at CHOP examined 65 patients who received 437 dinutuximab-containing cycles. Neurotoxicity occurred in 83.1% of patients and 36.4% of cycles, usually early in treatment, most often on day 1. Common symptoms included urinary retention, visual changes, and altered mental status. No clear links were found with age, sex, phase of therapy, or disease burden. Nurses frequently responded with PRN medications, bladder scans, catheters, pain control, and additional monitoring.<br /><br />The team also described a successful dinutuximab desensitization protocol for patients with prior severe allergic reactions. Six patients underwent desensitization across 33 cycles, mostly transitioning from PICU to oncology unit care. The protocol used a three-bag, 22-hour infusion with intensive supportive medications.<br /><br />Finally, they presented an outpatient initiation pathway to start dinutuximab in clinic before admission, reducing inpatient length of stay by 1–2 days and improving family satisfaction. Nurses were emphasized as essential to monitoring, education, and protocol development.

Keywords

dinutuximab

pediatric neuroblastoma

neurotoxicity

infusion reactions

desensitization protocol

GD2 target

outpatient initiation

high-risk disease

nursing care